CAT #: 40880098
LymphoTrack® B-cell Low Positive Control
The LymphoTrack Low Positive Controls (RUO) and LymphoQuant® Internal Controls (RUO) are used in conjunction with LymphoTrack assays to estimate the rearranged cell equivalents within each sample tested.
Minimal Residual Disease (MRD) testing by Next-Generation Sequencing (NGS) is a proven tool in the development of management strategies for hematologic malignancies. The LymphoTrack (RUO) Assays can be used for Minimal Residual Disease (MRD) assessment and tracking of rearranged clonal sequences. Once specific rearrangements have been identified, LymphoTrack Assays can be used with LymphoTrack Low Positive Controls and LymphoQuant Internal Controls to track these clonal populations with a sensitivity of 10-6 with sufficient DNA input. These LymphoTrack B-cell Low Positive Controls are used to verify the sensitivity of the assay.
Warranty and Liability
Invivoscribe, Inc. (Invivoscribe®) is committed to providing the highest quality products. Invivoscribe® warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert. If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe®. Invivoscribe® liability shall not exceed the purchase price of the product. Invivoscribe shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchaser’s laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of internally validated positive, negative, and blank controls every time a sample is tested. Ordering, acceptance and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.
This product is for Research Use Only; not for use in diagnostic procedures.
©2023 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe, Inc. and/or its affiliates, or (as to the trademarks of others used herein) their respective owners.